Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
NeuBase Therapeutics
(NBSE) Q2 2023
Earnings
NBSE
Aug 14
Confirmed
Dec 2022
Q4 2022
Q1 2023
Q2 2023
-2.04
-1.4
-0.75
-0.11
Details
Expected EPS
N/A
Actual EPS
-2.04
Surprise EPS
N/A
Surprise Percent
N/A
Description
NeuBase Therapeutics (NBSE) has reported earnings of -2.04 per share for Q2 2023.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login